72 related articles for article (PubMed ID: 3607783)
21. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Stevens MC; Rey A; Bouvet N; Ellershaw C; Flamant F; Habrand JL; Marsden HB; Martelli H; Sanchez de Toledo J; Spicer RD; Spooner D; Terrier-Lacombe MJ; van Unnik A; Oberlin O
J Clin Oncol; 2005 Apr; 23(12):2618-28. PubMed ID: 15728225
[TBL] [Abstract][Full Text] [Related]
22. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
25. Combination vincristine and VP-16-213: evaluation of drug sequence.
Jackson DV; Long TR; Rice DG; Morgan TM
Cancer Biochem Biophys; 1986 Oct; 8(4):265-75. PubMed ID: 3802048
[TBL] [Abstract][Full Text] [Related]
26. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365
[TBL] [Abstract][Full Text] [Related]
27. Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts.
Horton JK; Houghton PJ; Houghton JA
Biochem Pharmacol; 1988 Oct; 37(20):3995-4000. PubMed ID: 3190743
[TBL] [Abstract][Full Text] [Related]
28. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
29. Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition.
Dudkin L; Dilling MB; Cheshire PJ; Harwood FC; Hollingshead M; Arbuck SG; Travis R; Sausville EA; Houghton PJ
Clin Cancer Res; 2001 Jun; 7(6):1758-64. PubMed ID: 11410517
[TBL] [Abstract][Full Text] [Related]
30. Growth and characterization of childhood rhabdomyosarcomas as xenografts.
Houghton JA; Houghton PJ; Webber BL
J Natl Cancer Inst; 1982 Mar; 68(3):437-43. PubMed ID: 6950170
[TBL] [Abstract][Full Text] [Related]
31. [Combined treatment of rhabdomyosarcoma in children].
Armata J; Cyklis R; Legutko L; Małek T; Sitarska B; Turkiewicz A
Pol Tyg Lek; 1981 May; 36(19):675-7. PubMed ID: 6167974
[No Abstract] [Full Text] [Related]
32. [Rhabdomyosarcoma].
Hosoi H; Tsuchiya K; Sugimoto T
Gan To Kagaku Ryoho; 2007 Feb; 34(2):181-6. PubMed ID: 17301524
[TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study.
Verrills NM; Liem NL; Liaw TY; Hood BD; Lock RB; Kavallaris M
Proteomics; 2006 Mar; 6(5):1681-94. PubMed ID: 16456880
[TBL] [Abstract][Full Text] [Related]
34. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo.
Vucenik I; Kalebic T; Tantivejkul K; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1377-84. PubMed ID: 9673344
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the antitumor efficacy, pharmacokinetics, and pharmacodynamics of the histone deacetylase inhibitor depsipeptide in childhood cancer models in vivo.
Graham C; Tucker C; Creech J; Favours E; Billups CA; Liu T; Fouladi M; Freeman BB; Stewart CF; Houghton PJ
Clin Cancer Res; 2006 Jan; 12(1):223-34. PubMed ID: 16397046
[TBL] [Abstract][Full Text] [Related]
36. [Rhabdomyosarcoma: therapeutic results and prospectives].
Guglielmi M; Carli M
Pediatr Med Chir; 1984; 6(2):179-84. PubMed ID: 6549408
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat.
Jiang W; Jiang J; Xu D; Wang X; Qi S; Ouyang J; Ma A; Vu MD; Bilolo KK; Chen H
Microsurgery; 2003; 23(2):117-22. PubMed ID: 12740883
[TBL] [Abstract][Full Text] [Related]
38. [Transdermal and lymph targeting transfersomes of vincristine].
Lu Y; Hou SX; Zhang LK; Li Y; He JY; Guo DD
Yao Xue Xue Bao; 2007 Oct; 42(10):1097-101. PubMed ID: 18229621
[TBL] [Abstract][Full Text] [Related]
39. Vincristine by continuous infusion in refractory breast cancer: a phase II study.
Hopkins JO; Jackson DV; White DR; Muss HB; Richards F; Cooper MR; Stuart JJ; Sparr CL; Wells HB
Am J Clin Oncol; 1983 Oct; 6(5):529-32. PubMed ID: 6613919
[TBL] [Abstract][Full Text] [Related]
40. Effect of five antineoplastic agents on tumor xenografts with different growth rates.
Mattern J; Wayss K; Volm M
J Natl Cancer Inst; 1984 Jun; 72(6):1335-9. PubMed ID: 6587154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
